Vasoactive Intestinal Polypeptide Regulation of Rabbit Renal Adenylate Cyclase Activity in Vitro

Overview

Journal J Physiol

Specialty Physiology

Date 1987 Jun 1

PMID 3656172

Citations 5

Authors

N M Griffiths

N L Simmons

Affiliations

Soon will be listed here.

Abstract

1. The effect of vasoactive intestinal polypeptide (VIP) upon adenylate cyclase activity was determined in purified cortical basolateral membranes and in glomeruli and tubular elements obtained from rabbit kidney. 2. In purified basolateral membranes prepared from cortex, 1 microM-VIP consistently stimulated adenylate cyclase activity above basal levels (1.55 +/- 0.09-fold (mean +/- S.E. of mean), n = 10 animals). Half-maximal stimulation was observed at 17 +/- 11 nM-VIP (S.D., n = 9). 3. Related peptides, e.g. secretin, glucagon, gastric inhibitory peptide, human pancreatic growth hormone releasing factor, and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI), were without effect or gave lower stimulations of adenylate cyclase activity when tested at 1 microM. 4. Significant VIP degradation was observed under the assay conditions used but this did not substantially alter the response or selectivity to VIP. 5. In separate preparations of isolated glomeruli and proximal tubules addition of 1 microM-VIP resulted in a 3.3 +/- 1.1-fold (S.D., n = 3) and 2.2 +/- 1.0-fold (S.D., n = 3) stimulation (respectively) of adenylate cyclase activity. 6. In isolated medullary tubule suspensions, isolated by collagenase-hyaluronidase digestion of outer (red) medulla, and in thick ascending-limb-enriched preparations prepared by Percoll density gradient fractionation, 1 microM-VIP significantly increased adenylate cyclase activity by 2.4 +/- 0.6-fold (S.D., n = 3) and 2.1 +/- 0.7-fold (S.D., n = 3) respectively. 7. A possible role for VIP in the regulation of renal function in the rabbit is discussed in relation to the occurrence of VIP stimulation of adenylate cyclase activity in several renal cellular elements.

Citing Articles

Distribution of vasoactive intestinal peptide-sensitive adenylate cyclase activity along the rabbit nephron.

Griffiths N, Chabardes D, Imbert-Teboul M, Morel F, Simmons N Pflugers Arch. 1988; 412(4):363-8.

PMID: 3174393 DOI: 10.1007/BF01907553.

Kamata K, Sakamoto A, Kasuya Y Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(4):401-6.

PMID: 2854209 DOI: 10.1007/BF00172117.

Vasoactive intestinal peptide stimulation of renal adenylate cyclase and antagonism by (4Cl-D-Phe6Leu17)VIP.

Griffiths N, Simmons N, Rivier J Pflugers Arch. 1989; 414(2):222-7.

PMID: 2755776 DOI: 10.1007/BF00580967.

Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.

Charlton B, Neal D, Simmons N J Physiol. 1990; 423:475-84.

PMID: 2167366 PMC: 1189769. DOI: 10.1113/jphysiol.1990.sp018034.

Localisation and characterisation of functional vasoactive intestinal peptide receptors in feline kidney.

Griffiths N, Simmons N Pflugers Arch. 1990; 416(1-2):80-7.

PMID: 2162036 DOI: 10.1007/BF00370226.

References

Brown B, Albano J, Ekins R, Sgherzi A . A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971; 121(3):561-2. PMC: 1176606. DOI: 10.1042/bj1210561. View

COOK W, PICKERING G . A rapid method for separating glomeruli from rabbit kidney. Nature. 1958; 182(4642):1103-4. DOI: 10.1038/1821103a0. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Keltz T, STRAUS E, Yalow R . Degradation of vasoactive intestinal polypeptide by tissue homogenates. Biochem Biophys Res Commun. 1980; 92(2):669-74. DOI: 10.1016/0006-291x(80)90385-x. View

Bataille D, Gespach C, Laburthe M, Amiranoff B, Tatemoto K, Vauclin N . Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat. FEBS Lett. 1980; 114(2):240-2. DOI: 10.1016/0014-5793(80)81124-0. View

Dousa T, Shah S, Abboud H . Potential role of cyclic nucleotides in glomerular pathophysiology. Adv Cyclic Nucleotide Res. 1980; 12:285-99. View

Bailly C, Imbert-Teboul M, Chabardes D, Hus-Citharel A, Montegut M, Clique A . The distal nephron of rat kidney: a target site for glucagon. Proc Natl Acad Sci U S A. 1980; 77(6):3422-4. PMC: 349628. DOI: 10.1073/pnas.77.6.3422. View

Chung S, Alavi N, Livingston D, Hiller S, Taub M . Characterization of primary rabbit kidney cultures that express proximal tubule functions in a hormonally defined medium. J Cell Biol. 1982; 95(1):118-26. PMC: 2112352. DOI: 10.1083/jcb.95.1.118. View

Dharmsathaphorn K, Harms V, Yamashiro D, Hughes R, Binder H, Wright E . Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes. J Clin Invest. 1983; 71(1):27-35. PMC: 436834. DOI: 10.1172/jci110748. View

10.

Porter J, Said S, Ganong W . Vasoactive intestinal peptide stimulates renin secretion in vitro: evidence for a direct action of the peptide on the renal juxtaglomerular cells. Neuroendocrinology. 1983; 36(5):404-8. DOI: 10.1159/000123488. View

11.

Podevin R . Isolation of basolateral and brush-border membranes from the rabbit kidney cortex. Vesicle integrity and membrane sidedness of the basolateral fraction. Biochim Biophys Acta. 1983; 735(1):86-94. DOI: 10.1016/0005-2736(83)90263-8. View

12.

Dimaline R, Peart W, Unwin R . Effects of vasoactive intestinal polypeptide (VIP) on renal function and plasma renin activity in the conscious rabbit. J Physiol. 1983; 344:379-88. PMC: 1193847. DOI: 10.1113/jphysiol.1983.sp014946. View

13.

Calam J, Dimaline R, Peart W, Singh J, Unwin R . Effects of vasoactive intestinal polypeptide on renal function in man. J Physiol. 1983; 345:469-75. PMC: 1193808. DOI: 10.1113/jphysiol.1983.sp014989. View

14.

Lance V, Murphy W, Coy D . Structure-activity studies on the N-terminal region of glucagon. J Med Chem. 1984; 27(3):310-5. DOI: 10.1021/jm00369a014. View

15.

BARAJAS L, Sokolski K, Lechago J . Vasoactive intestinal polypeptide-immunoreactive nerves in the kidney. Neurosci Lett. 1983; 43(2-3):263-9. DOI: 10.1016/0304-3940(83)90199-4. View

16.

Simmons N, Brown C, Rugg E . The action of epinephrine on Madin-Darby canine kidney cells. Fed Proc. 1984; 43(8):2225-9. View

17.

Rugg E, Simmons N . Control of cultured epithelial (MDCK) cell transport function: identification of a beta-adrenoceptor coupled to adenylate cyclase. Q J Exp Physiol. 1984; 69(2):339-53. DOI: 10.1113/expphysiol.1984.sp002810. View

18.

Chamberlin M, LeFurgey A, Mandel L . Suspension of medullary thick ascending limb tubules from the rabbit kidney. Am J Physiol. 1984; 247(6 Pt 2):F955-64. DOI: 10.1152/ajprenal.1984.247.6.F955. View

19.

Couvineau A, Laburthe M . The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor. Biochem J. 1985; 225(2):473-9. PMC: 1144613. DOI: 10.1042/bj2250473. View

20.

Waelbroeck M, Robberecht P, Coy D, CAMUS J, De Neef P, Christophe J . Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology. 1985; 116(6):2643-9. DOI: 10.1210/endo-116-6-2643. View